Induction of a Specific Humoral Immune Response by Nasal Delivery of Bcla2ctd of Clostridioides difficile
Authors:
- Ana Raquel MaiaAMAna Raquel Maia
- Rodrigo Reyes-RamírezRRRodrigo Reyes-Ramírez
- Marjorie Pizarro-GuajardoMPMarjorie Pizarro-Guajardo
- Anella SaggeseASAnella Saggese
- Pablo Castro-CórdovaPCPablo Castro-Córdova
- Rachele IsticatoRIRachele Isticato
- Ezio RiccaEzio Ricca
- Daniel Paredes-SabjaDaniel Paredes-Sabja
- Loredana BaccigalupiLoredana Baccigalupi
Open Access
- 14 February 2020
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (4) , 1277
Abstract
Clostridioides difficile, formerly known as Clostridium difficile, is a spore-forming bacterium considered as the most common cause of nosocomial infections in developed countries. The spore of C. difficile is involved in the transmission of the pathogen and in its first interaction with the host; therefore, a therapeutic approach able to control C. difficile spores would improve the clearance of the infection. The C-terminal (CTD) end of BclA2, a spore surface protein of C. difficile responsible of the interaction with the host intestinal cells, was selected as a putative mucosal antigen. The BclA2 fragment, BclA2CTD, was purified and used to nasally immunize mice both as a free protein and after adsorption to the spore of Bacillus subtilis, a well-established mucosal delivery vehicle. While the adsorption to spores increased the in vitro stability of BclA2CTD, in vivo both free and spore-adsorbed BclA2CTD were able to induce a similar, specific humoral immune response in a murine model. Although in the experimental conditions utilized the immune response was not protective, the induction of specific IgG indicates that free or spore-bound BclA2CTD could act as a putative mucosal antigen targeting C. difficile spores.Keywords
Funding Information
- Università degli Studi di Napoli Federico II (SP-LAY: Bacterial spores as live platform for proteins display)
- Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT Grant 1191601)
- Fondo de Fomento al Desarrollo Científico y Tecnológico (FONDEF ID18/10230)
This publication has 43 references indexed in Scilit:
- Non-recombinant display of the B subunit of the heat labile toxin of Escherichia coli on wild type and mutant spores of Bacillus subtilisMicrobial Cell Factories, 2013
- Adsorption of β-galactosidase of Alicyclobacillus acidocaldarius on wild type and mutants spores of Bacillus subtilisMicrobial Cell Factories, 2012
- The Clostridium difficile spo0A Gene Is a Persistence and Transmission FactorInfection and Immunity, 2012
- Cefoperazone-treated mice as an experimental platform to assess differential virulence ofClostridium difficilestrainsGut Microbes, 2011
- Immunization with Bacillus Spores Expressing Toxin A Peptide Repeats Protects against Infection with Clostridium difficile Strains Producing Toxins A and BInfection and Immunity, 2011
- Clostridium difficile InfectionThe American Journal of the Medical Sciences, 2010
- CotE Binds to CotC and CotU and Mediates Their Interaction during Spore Coat Formation in Bacillus subtilisJournal of Bacteriology, 2010
- A Systematic Assessment of MHC Class II Peptide Binding Predictions and Evaluation of a Consensus ApproachPLOS Computational Biology, 2008
- A consensus epitope prediction approach identifies the breadth of murine TCD8+-cell responses to vaccinia virusNature Biotechnology, 2006
- Metronidazole Resistance in Clostridium difficileClinical Infectious Diseases, 2000